Category

India

Daily Brief India: Northern Arc Capital, Adani Transmission and more

By | Daily Briefs, India

In today’s briefing:

  • Northern Arc Capital Pre-IPO Tearsheet
  • Morning Views Asia: Rakuten Group , UPL Ltd


Northern Arc Capital Pre-IPO Tearsheet

By Clarence Chu

  • Northern Arc Capital (0542390D IN) is looking to raise at least US$100m in its upcoming India IPO. The bookrunners on the deal are Citigroup, Axis Capital, and ICICI Securities.
  • Northern Arc Capital (NAC) is a retail-focused non-banking financial company (NBFC) catering its banking services to the under-served households and businesses in India.
  • According to CRISIL, NAC was one of the leading players amongst India’s diversified NBFCs in terms of AUM as of Mar 23.

Morning Views Asia: Rakuten Group , UPL Ltd

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Stylam Industries, SBI Cards & Payment Services, Bharti Hexacom and more

By | Daily Briefs, India

In today’s briefing:

  • Stylam Industries (SYIL IN) 3QFY24: Concall Highlights, Margin Expansion
  • Fundamental Shorts – SBI Cards | PVR Inox | Escorts Kubota
  • Bharti Hexacom Pre-IPO – The Negatives – No Clear Rationale for Listing


Stylam Industries (SYIL IN) 3QFY24: Concall Highlights, Margin Expansion

By Sameer Taneja

  • Stylam Industries (SYIL IN) reported its best-ever EBITDA margin of 22.3% Vs 16.8% due to a raw material price decline. Revenues continued to remain soft, with growth of -8% YoY.
  • The company completed its brownfield expansion to increase the plant capacity by 40% and is now embarking on a capacity expansion of 200 crores in FY25, effectively doubling its revenues. 
  • Stylam Industries (SYIL IN) trades at 22x/19x FY24e/25e, with a potential for doubling of revenues over the next 3-5 years.

Fundamental Shorts – SBI Cards | PVR Inox | Escorts Kubota

By Pranav Bhavsar


Bharti Hexacom Pre-IPO – The Negatives – No Clear Rationale for Listing

By Sumeet Singh

  • Bharti Hexacom is looking to raise up to US$1bn in its upcoming India IPO.
  • Bharti Hexacom (BH) is a communications solutions provider offering consumer mobile services, fixed-line telephone and broadband services to customers in the Rajasthan and the North East telecommunication circles in India.
  • In this note, we talk about the not-so-positive aspects of the deal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: GMR Airports Infrastructure, Bharti Hexacom, Dr. Reddy’s Laboratories and more

By | Daily Briefs, India

In today’s briefing:

  • GMR Airports Infra (GMRI IN): Flying High
  • Bharti Hexacom Pre-IPO – The Positives – Earnings Have Been Recovering Well
  • Dr. Reddy’s Laboratories (DRRD IN): US and Europe Drive Highest Ever Sales in Q3; Profit Surges 11%


GMR Airports Infra (GMRI IN): Flying High

By Brian Freitas


Bharti Hexacom Pre-IPO – The Positives – Earnings Have Been Recovering Well

By Sumeet Singh

  • Bharti Hexacom is looking to raise up to US$1bn in its upcoming India IPO. 
  • Bharti Hexacom (BH) is a communications solutions provider offering consumer mobile services, fixed-line telephone and broadband services to customers in the Rajasthan and the North East telecommunication circles in India.
  • In this note, we talk about the positive aspects of the deal.

Dr. Reddy’s Laboratories (DRRD IN): US and Europe Drive Highest Ever Sales in Q3; Profit Surges 11%

By Tina Banerjee

  • In Q3FY24, Dr. Reddy’s Laboratories (DRRD IN) posted highest ever revenue of INR72B, led by U.S. and Europe generics businesses, with contribution from both base business and new product launches.
  • Underperformance in the domestic market continued in Q3FY24. However, the company’s initiatives regarding innovative and new generic drugs for Indian market should place it for long-term accelerated growth.
  • Last month, Dr. Reddy’s acquired MenoLabs, a leading women’s health and dietary supplement branded portfolio of seven products designed to provide health support and address symptoms of perimenopause and menopause.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Maithan Alloys, LIC Housing Finance and more

By | Daily Briefs, India

In today’s briefing:

  • Maithan Alloys (NSE:MAITHANALL) – Monday, Nov 13, 2023
  • LICHF: FY24 PAT Is on Track to Be Strong | FY25 Will Be a Year of Robust Growth


Maithan Alloys (NSE:MAITHANALL) – Monday, Nov 13, 2023

By Value Investors Club

Key points (machine generated)

  • Maithan Alloys is a leading manufacturer of Manganese (Mn) alloys used in the production of hardened steel.
  • The company operates three plants in India and recently acquired a fourth, indicating its growth and expansion in the industry.
  • India, where Maithan Alloys is based, is the largest exporter of Mn alloys in the world, providing 25% of global imports, and maintains its position as a low-cost supplier despite structural disadvantages.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


LICHF: FY24 PAT Is on Track to Be Strong | FY25 Will Be a Year of Robust Growth

By Ankit Agrawal, CFA

  • LIC Housing Finance (LICHF) reported a strong Q3FY24 on the back of a strong NIM. Growth, however, has been tepid as LICHF recently transitioned its technology and organizational structure.
  • FY24 has been a consolidation year due to technology and organizational changes; however, LICHF is setting up well to post strong growth in FY25.
  • Among other things, affordable housing is going to be a key growth area going forward. Asset quality has been also improving and should further normalize with recoveries and upgradations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Zydus Lifesciences Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Zydus Lifesciences (ZYDUSLIF IN): Strong India Momentum; Q3 Net Profit Jumps 27%; Buyback Approved


Zydus Lifesciences (ZYDUSLIF IN): Strong India Momentum; Q3 Net Profit Jumps 27%; Buyback Approved

By Tina Banerjee

  • Zydus Lifesciences Ltd (ZYDUSLIF IN) reported 16% YoY and 7% QoQ growth in India formulation business revenue in Q3FY24 on the back of healthy volume growth and new product launches.
  • Profitability improvement continued, with Q3FY24 improving 200 basis points YoY to 24.5%. Net profit surged 27% YoY.
  • The Board approved INR6 billion buyback, representing 0.59% of total outstanding equity shares at a price of INR1005 per share (25% premium to last closing price) via tender offer route.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Infosys Ltd, Bajaj Finance Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: STAR100, NEXT50, LowVol30, KOSPI200, TW50, NWD, ITC, India Float
  • Bajaj Finance (BAF): A Sustained Growth Powerhouse


Index Rebalance & ETF Flow Recap: STAR100, NEXT50, LowVol30, KOSPI200, TW50, NWD, ITC, India Float

By Brian Freitas

  • There will be a bunch of rebalance announcements towards the start and at the end of the coming week. This includes the HSI, HSCEI, HSTECH, HSCI, HSIII and global indices.
  • The review period for the March rebalance of the S&P/ASX 200 and related indices ends on 16 February. The announcement of the changes will come couple of weeks later.
  • There were HUGE inflows to mainland China ETFs for yet another week as Central Huijin indicated that they would continue to buy/create ETFs units.

Bajaj Finance (BAF): A Sustained Growth Powerhouse

By Ankit Agrawal, CFA

  • Q3FY24 performance was slightly below expectation led by NIM margin compression and marginally elevated credit costs. Certain regulatory restrictions also dampened growth and profitability.
  • However, from a medium-term perspective, BAF is setting up well to be a sustained growth powerhouse. It has widened its product catalogue and is deepening the product availability per branch.
  • Led by growth tailwinds and market share gains, BAF has potential to grow at 25%+ for a prolonged period. The current headwinds seem temporary and provide a buying opportunity.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: NIFTY Index and more

By | Daily Briefs, India

In today’s briefing:

  • EQD | NIFTY’s Uncertainty: The Rally Could Pause for 1 More Week


EQD | NIFTY’s Uncertainty: The Rally Could Pause for 1 More Week

By Nico Rosti

  • The NIFTY Index was supposed to continue its rally but has stalled a bit this week.
  • This modest pullback could be a buy-the-dip opportunity, based on our WEEKLY models reading.
  • The price support area to buy is between the Last WEEKLY Close and  21229.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: ITC Ltd, Agilus Diagnostics Limited, Paytm, Bank Of Baroda, SBFC Finance Limited, Entero Healthcare Solutions Limited and more

By | Daily Briefs, India

In today’s briefing:

  • ITC Ltd (ITC IN): Impact of BAT’s Potential Stake Sale
  • Agilus Diagnostics Limited Pre-IPO – Still Recovering from COVID
  • The Paytm Saga: A Tale of Non-Compliance and Controversy
  • Indian Banks Screener: Bank of Baroda Remains the Value Pick, HDFC Bank Is the Quality Name
  • SBFC Finance Lockup Expiry – Time to Cash in on Some Hefty Profits
  • Entero Healthcare IPO – Profitability Not Out of the Woods Yet


ITC Ltd (ITC IN): Impact of BAT’s Potential Stake Sale

By Brian Freitas

  • British American Tobacco (BATS LN) owns 29.03% of ITC Ltd (ITC IN) and could sell a portion of its stake. But BAT will hold at least 25% of the company.
  • British American Tobacco (BATS LN) paring its stake could also lead to SUUTI gradually reducing its own holding in the company.
  • Any stake sales would not result in buying from global passive trackers while there will be small buying from local index trackers. Increased float could pressure the stock.

Agilus Diagnostics Limited Pre-IPO – Still Recovering from COVID

By Sumeet Singh

  • Agilus Diagnostics Limited (SRLL IN) is looking to raise around US$200m in its upcoming India IPO.
  • Agilus Diagnostics Limited (Agilus) is a diagnostic testing service provider.
  • In this note, we look at the company’s past performance.

The Paytm Saga: A Tale of Non-Compliance and Controversy

By Nimish Maheshwari

  • Paytm Payments Bank faces regulatory scrutiny and compliance challenges, impacting its trajectory and profitability amid ongoing supervisory action by the RBI.
  • With significant restrictions on operations and revenue streams, Paytm navigates a complex financial landscape, highlighting resilience amidst regulatory uncertainties and governance concerns.
  • Despite proactive measures, including partnership diversification and service continuity, Paytm’s future hinges on addressing compliance lapses and fostering transparent governance to regain trust in the fintech sector.

Indian Banks Screener: Bank of Baroda Remains the Value Pick, HDFC Bank Is the Quality Name

By Victor Galliano

  • We retain Bank of Baroda as the value Indian bank, despite its strong share performance, for its modest valuations, healthy ROE and further improvements in delinquency metrics
  • HDFC Bank remains out of favour with the market but we retain it as a buy, with its potential for medium term gains post-merger and its strong balance sheet
  • Axis bank remains on our watchlist; we remain negative on State Bank of India for its delinquency risks, low core capital ratio and limited progress on returns

SBFC Finance Lockup Expiry – Time to Cash in on Some Hefty Profits

By Ethan Aw

  • SBFC Finance Limited (SBFC IN) raised around US$131m in its India IPO, after the deal was priced at INR57/share. Its six-month lockup will expire on 12th Feb 2024. 
  • SBFC Finance is a systematically important, non-deposit taking non-banking finance company (NBFC-ND-SI), offering secured MSME Loans and Loans against Gold.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

Entero Healthcare IPO – Profitability Not Out of the Woods Yet

By Clarence Chu

  • Entero Healthcare Solutions Limited (2294842D IN) is looking to raise US$193m in its India IPO.
  • Entero Healthcare Solutions (Entero) is a healthcare products distributor in India.
  • In this note, we will look at the RHP updates, undertake a peer comparison, and share our thoughts on valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Nameson Holdings, KPIT Technologies, ENN Natural Gas and more

By | Daily Briefs, India

In today’s briefing:

  • Morning Views Asia: Sands China, Tata Motors ADR, UPL Ltd
  • KPIT: On Track to Beat the FY24 Raised Guidance
  • Morning Views Asia: ENN Natural Gas, UPL Ltd


Morning Views Asia: Sands China, Tata Motors ADR, UPL Ltd

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


KPIT: On Track to Beat the FY24 Raised Guidance

By Ankit Agrawal, CFA

  • Despite upping the FY24 guidance in the prior quarter (Q2FY24), KPIT is confident of beating even the raised guidance, led by strong Q3FY24 performance and an upbeat outlook.
  • Despite accelerated revenue in H1FY24 from the Honda engagement, Q3FY24 saw robust revenue growth of 4.3% QoQ in CC terms. EBITDA margin expanded to 20.6% vs 20% QoQ. 
  • KPIT’s new venture, Qorix, is coming along well and could prove to be transformative. This could enable KPIT to become a product company, alongside being a high-growth service company.

Morning Views Asia: ENN Natural Gas, UPL Ltd

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Power Finance, Titan Co Ltd, State Bank Of India, Guangzhou R&F Properties and more

By | Daily Briefs, India

In today’s briefing:

  • NIFTY NEXT50 Index Rebalance Preview: Potential Adds Continue to Run
  • NIFTY100 Low Volatility 30 Index Rebalance Preview: One Change in March
  • State Bank of India (SBIN) – 3Q24 Update: Short-Term Pressure Is an Opportunity to Accumulate
  • Morning Views Asia: Bharti Airtel, Guangzhou R&F Properties, UPL Ltd


NIFTY NEXT50 Index Rebalance Preview: Potential Adds Continue to Run

By Brian Freitas

  • With the review period for the March rebalance complete, there could be 6 potential changes for the NSE Nifty Next 50 Index (NIFTYJR INDEX) using the current index methodology.
  • Estimated one-way turnover is 13.9% resulting in a one-way trade of INR 28.6bn. Four inclusions will have over 1x ADV to buy; five deletions will have 2.5x+ ADV to sell.
  • The potential adds have outperformed the potential deletes by 28.6% over the last month. With positioning from a rebalance perspective mostly done, gradually unwind over the next few weeks.

NIFTY100 Low Volatility 30 Index Rebalance Preview: One Change in March

By Brian Freitas

  • There could be one change for the Nifty100 Low Volatility 30 Index that will be implemented at the close on 28 March.
  • Constituent changes, volatility changes and capping changes will result in one-way turnover of 12.6% and in a one-way trade of INR 3.7bn.
  • While the deletion is fairly certain, there are a few non-constituents around the same level of volatility and price movements over the next few weeks will determine the inclusion.

State Bank of India (SBIN) – 3Q24 Update: Short-Term Pressure Is an Opportunity to Accumulate

By Raj Saya, CA, CFA

  • State Bank Of India (SBIN IN) has reported its 3Q24 (Dec-23) results with a one-off pension and wages revision charge which impacts the short-term earnings profile.
  • Medium-Term ROE Forecast Intact (16% to 18%) with management confident of even touching 20% in next couple of years; loan growth forecast of 14% to 16% for FY25e-FY26e.
  • We reiterate our view: P/BV is cheap at 1.3x FY25e. SBIN has the potential to re-rate to P/BV of ~1.6x FY25e in the near term (~40% upside). Opportunity to ADD.

Morning Views Asia: Bharti Airtel, Guangzhou R&F Properties, UPL Ltd

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars